Synthetic biology: A big step towards an artificial yeast genome | The Economist https://t.co/H08ZxWf2JE — The Propell Group (@ThePropellGroup) March 31, 2017 #healthtech
Counsel of protection: The coming revolution in insurance | The Economist https://t.co/WX7udyHls5 — The Propell Group (@ThePropellGroup) March 30, 2017 #healthtech
Global Healthcare | 14 Deals, Investments & Transactions | Week 12 – Mar 2017 https://t.co/XTvYpqL7d4 — The Propell Group (@ThePropellGroup) March 30, 2017 #healthtech
Digital Health Sees $1B+ Exits But Is Still Waiting For A Big Success https://t.co/gZNUNMtwBe — The Propell Group (@ThePropellGroup) March 30, 2017 #healthtech
My breakfast with the cancer bubble https://t.co/p8cdkTEGcG — The Propell Group (@ThePropellGroup) March 29, 2017 #healthtech
Google’s DeepMind plans bitcoin-style health record tracking for hospitals https://t.co/gfQAFSN1Op — The Propell Group (@ThePropellGroup) March 29, 2017 #healthtech
“Global Healthcare | 14 Deals, Investments & Transactions | Week 12 – Mar 2017” https://t.co/XRUxkdmU3l by @ThePropellGroup on @LinkedIn — The Propell Group [...]
Scientists want to borrow power from your phone to cure cancer https://t.co/qBVJ9jnFwS — The Propell Group (@ThePropellGroup) March 28, 2017 #healthtech
Digital Health – Benefits and value for the growth markets – Growth Markets https://t.co/yxOLZnWL5f via @PwC_UK — The Propell Group (@ThePropellGroup) March 28, 2017 #healthtech
How Sherpaa Survived Venture Capital’s Unrealistic Expectations | Fast Company https://t.co/R7109eVCvX — The Propell Group (@ThePropellGroup) March 28, 2017 #healthtech